Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06442553
Status:
COMPLETED
Last Update Posted:
2024-06-04
First Post:
2024-05-29
Brief Title:
New Generation Low Level Laser Effect in Myofacial Pain Syndrome
Sponsor:
University of Gaziantep
Organization:
University of Gaziantep
Study Overview
Official Title:
New Generation Low Level Laser Effect on Masseter Muscle Oxygenation Bite Force and Algometric Changes in Myofacial Pain Syndrome A Randomised Placebo-controlled Clinical Trial
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Low level laser treatments have been used to treat painful trigger points in myofascial pain syndrome MPS but the effectiveness of the appropriate laser type and parameters is still uncertain The aim of this study was to compare the effectiveness of different types of low level laser treatment LLLT in reducing pain levels changing oxygen saturation and bite force in patients with MPS
Detailed Description:
A total of 45 patients with MPS were randomly divided into three groups First group received LLLT with GRR laser over massater muscle region Patients in the second group were treated with NdYAG laser and the same protocol with NdYAG laser was performed in the placebo group using sham device Pain was evaluated by visual analogue scale VAS change in oxygen concentration in the massater muscle was measured by functional near-infrared spectroscopy- fNIRS and bite force was measured with Flexiforce sensors before and after treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None